Mealey's (October 18, 2022, 4:08 PM EDT) -- WASHINGTON, D.C. — Pfizer Inc. has asked the U.S. Supreme Court to review an appeals court ruling that a patient assistance program for a $225,000-a-year heart drug violates the Anti-Kickback Statute (AKS)....